HomeSHTDY • OTCMKTS
add
Sinopharm Group ADR
Nakaraang pagsara
$11.74
Sakop ng araw
$11.73 - $11.86
Sakop ng taon
$10.13 - $16.31
Market cap
57.11B HKD
Average na Volume
16.90K
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 141.66B | -3.81% |
Gastos sa pagpapatakbo | 6.72B | -6.59% |
Net na kita | 1.46B | 2.59% |
Net profit margin | 1.03 | 7.29% |
Kita sa bawat share | — | — |
EBITDA | 3.70B | -5.19% |
Aktuwal na % ng binabayarang buwis | 23.38% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 45.36B | -32.44% |
Kabuuang asset | 415.08B | — |
Kabuuang sagutin | 285.93B | — |
Kabuuang equity | 129.16B | — |
Natitirang share | 3.12B | — |
Presyo para makapag-book | 0.45 | — |
Return on assets | 1.96% | — |
Return on capital | 3.85% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.46B | 2.59% |
Cash mula sa mga operasyon | -34.28B | 27.81% |
Cash mula sa pag-invest | 617.49M | 141.09% |
Cash mula sa financing | 12.88B | -41.88% |
Net change in cash | -20.78B | 17.10% |
Malayang cash flow | -14.13B | — |
Tungkol
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Itinatag
2003
Website
Mga Empleyado
108,217
